Bausch & Lomb (TSX:BLCO) Inventories, Raw Materials & Components : C$365 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Inventories, Raw Materials & Components?

Bausch & Lomb's inventories, raw materials & components for the quarter that ended in Mar. 2024 was C$365 Mil.

Bausch & Lomb's quarterly raw materials increased from Sep. 2023 (C$271 Mil) to Dec. 2023 (C$350 Mil) and increased from Dec. 2023 (C$350 Mil) to Mar. 2024 (C$365 Mil).

Bausch & Lomb's annual raw materials increased from Dec. 2021 (C$188 Mil) to Dec. 2022 (C$221 Mil) and increased from Dec. 2022 (C$221 Mil) to Dec. 2023 (C$350 Mil).

Bausch & Lomb Inventories, Raw Materials & Components Historical Data

The historical data trend for Bausch & Lomb's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Inventories, Raw Materials & Components Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

205.44

185.73

188.16

221.44

350.16

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Raw Materials & Components	Get a 7-Day Free Trial												246.29	253.76	270.62	350.16	365.47

Bausch & Lomb Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives